Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

TnJ > 68.OA > Flashcards

68.OA Flashcards

1
Q

define arthritis

A

disease process within the synovial jointClassified as noninflammatory vs inflammatorybut all display some form of inflammation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

“noninflammatory” arthritis

A
  1. OSTEOARTHRITIS (DJD, OA, osteoarthrosis)almost always SECONDARY20% adult dogs; 60% adult cats (can be primary in cats)key tissue = ARTICULAR CARTILAGE2. Traumatic3. Coagulopathic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Etiology of osteoarthritis

A

G-A-B-O-G-E1. Genetics: multiple genes2. Age: incr age= less aggrecans, slow responsiveness to anabolism3. BW: Boxer w hi birthweight, incr risk hip dysplasia/CCL4. Obesity: Lab cohort study signs of OA/HD w ad libitum feeding 42 vs 4% @ 2 YO 5. Gender: neutered boxer 1.5 x risk HD; neutering male/female incr risk CCLR6. Environment: leash exercise (exercise increases VI, PVF in OA patients), diet, housing (slippery floors)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

van Hagen et al Incidence, risk factors, and heritability estimates of hind limb lameness caused by hip dysplasia in a birth cohort of Boxers. Am J Vet Res. 2005

A

neutering at least 6 months before making a dx of clinical hip dysplasia influenced the risk of clinical HD developing over timeneutered Boxers were 1.5 x more likely to develop clinical HD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Beraud, R, Moreau, M, Lussier, B Effect of exercise on kinetic gait analysis of dogs afflicted by osteoarthritis. Vet Comp Orthop Traumatol 2010

A

force platform GAcontrol and OA dogsbaseline and post exerciseno change with control grouppeak, impulse, and propulsion vertical force values were sign lower post exercise (exercise actually improved limb use)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

central theme to pathogenesis of osteoarthritis

A

alterations in metabolism/morphology articular cartilagechanges in subchondral bone metabolism/architecture (sclerosis)osteophyte/enthesiophyte formationsynovial inflammation and fibrosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

3 overlapping stages of articular cartilage pathogenesis in OA

A
  1. ECM degrades, incr water content, decr aggrecan/P size, damage to collegen network–>reduce compressive stiffness2. chondrocytes compensate–prolif (anabolic–thickness stage)3. chondrocytes depleted, complete loss of cartilage tissue (ulcer, eburnation, erosion)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what substance/protein br eaks down type II collagen

A

intact triple helix of type II collagen can be degraded by MMP 1 and 13 (+/- 8, 14)and aggrecanases

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

arthroscopic outerbridge classification for OA

A

0 normal cartilageI softening and swelling of cartilageII fragment/fissuring of area < 0.5 inIII Fragment/fissuring of area > 0.5 inIV cartilage erosion/ eburnated bone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

surgical mgmt for OA

A
  1. joint debride/micropick (abrasion chondroplasty)–stimulate fibrocartilage2. joint replacement (hip, elbow, knee)3. arthrodesis/salvage excision arthroplasty4. amputation5. euthanasia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

normal synovial fluid analysis

A

< 2n x 10^9 TNCC94-100% mononuclear0-6 % PMN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

OA synovial fluid

A

< 2-5 x 10^9 TNCC88-100% mononuclear0-12 % PMN(similiar to normal OA) mild inflammatory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

RA (erosive) synovial fluid

A

< 8-38 x 10^9 TNCC20-80% mononuclear20-80 % PMN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

nonerosive IMPA synovial fluid

A

< 4-37 x 10^9 TNCC5-85% mononuclear15-95 % PMN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

infective arthritis synovial fluid

A

< 40-267 x 10^9 TNCC 1-10% mononuclear90-100% PMN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

medical mgmt for OA

A
  1. weight mgmt-exercise, rx diet, rx (microsomal triglyceride transfer P inhibitor)2. exercise–regular, moderate, controlled3. RX–symptom (NSAID) vs structural (stop cartilage damage) rx4. Nutrition (nutraceutical vs functional food J/D)5. Mesenchymal (multi potent) stem cell tx
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

MOA of NSAIDs

A
  1. Cyclooxygenase (COX) inhibitionwith COX inhibition, AA does not convert to PG (PGE2) thus no vasodilation, edema, incr pain noted2. Lipoxygenase (LIPOX) inhibitionif COX path is blocked, incr LIPOX path to make leukotrienes (proinflm, incr PMN, hyperalgesia)Ideally, NSAID would be LIPOX/COX inhibitors
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

COX 1 vs COX 2

A

COX 1 constitutive, in many tissues (makes PGs important for normal physiologic function)COX 2 inducible, upregulated w inflm; IS CONSTITUTIVE in kidney, brain and is cytoprotective to GI mucosaselective inhibition of COX 2 without affecting COX 1 will allow analgesia WITHOUT unwanted side effects of Cox 1 inhibitionGOAL: inhibition of COX2 at lower concentration than the concentration needed to inhibit COX1 (either a HIGH COX1:COX2 ratio or LOW COX2:COX1 ratio) pg 1057 Boothe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

adverse effects of NSAIDs

A

GI–vomiting, diarrhea, inappetanceimpaired platelet activity–decr thromboxane (COX 1 selective action)nephrotoxic–PGE2/PGE1 maintain renal BF (COX 1 and COX2 actions)hepatotoxic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

prostaglandins and their role for GI integrity

A

NSAIDS inhibit COX and decrease PG synthesisnatural GI integrity protected by PG mediated: 1. bicarbonate rich mucus2. gastric epithelial cell turnover at apical membrane3. high blood flow to release bicarbonate and neutralize any acid (decr H); also brings oxygen and nutrientsPGE2 maintains mucosal layer, mucus layer, blood flow, and gastric acid production and is made through COX 1 path

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

carprofen

A

propionic acid derived NSAIDconsidered COX 2 selective (COX1:COX2 ratio = 17)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

deracoxib

A

coxib derived NSAIDgreater bioavailability with food

23
Q

etodolac

A

indole acetic acid derived NSAIDboth COX1 (»>) and COX2 inhibitionlong serum half life–> 10-15 mg/kg PO SIDbiliary excretion and enterohepatic recirculationAdditional side effect: KCS

24
Q

firocoxib

A

pyridylsulfone derived NSAID (previcox) COX 2 selective5 mg/kg PO SIDcan be given with or without food

25
Q

ketoprofen

A

propionic acid derivative NSAIDCOX1 selective (CONTRAST TO CARPROFEN)0.25 mg/kg PO SID

26
Q

meloxicam

A

oxicam derived NSAIDCOX 2 selectiveratio COX1:COX2 = 3 NOT for cats in USAdog 0.2 mg/kg loading dose PO SID followed by 0. 1 mg/kg PO SID

27
Q

robenacoxib

A

coxib derived NSAIDhighly COX 2 selectiveCOX1:COX2 ratio 140biliary and renal excretionhigher bioavailability WITHOUT food

28
Q

COX and LIPOX inhibitor NSAID with approval in EUROPE

A

TEPOXALINnonselective COX and LIPOX inhibitor10 mg/kg PO SID for up to 28 days10% GI side effects

29
Q

amantadine

A

NMDA receptor antagonist3-5 mg/kg PO SIDneuropathic painstudy with meloxicam only showed slight benefit of amantadine added to regime–subjective criteria

30
Q

gabapentin

A

GABA analogue– not liscened10 mg/kg PO TID dog 5 mg/kg PO TID cattaper down to avoid rebound painneuropathic pain

31
Q

acetominophen

A

centrally acting analgesicNO USE IN CATS10-15 mg/kg q8-12hr DOGmaybe modulates serotonin in descending inhibitory pathways of paintoxicity in dogs >100 mg/kg

32
Q

preferred intraarticular steroids

A

methylprednisolonetriamcinolonelong lasting for IA injectionrisk cartilage damage (controversial)

33
Q

structure modifying agents for OA treatment

A

Polysulfated glycosaminoglycan (Adequan) 2 mg/lb IM twice weekly for 4 weeksmay maintain chondrocyte viability/prolif, protect ECM degradation

34
Q

nutritional mgmt for OA

A

chondroitin sulfate –poor bioavail (5%), insufficient evidence, may not reach articular surfaceglucosamine–90% bioavail, incr protein and aggrecan synthesis; reaches articular surfacePUFA (contain more than 1 carbon -carbon double bond): linoleic (6), linolenic (3)3-FA may decr mRNA for proteinases and MMPs

35
Q

types of inflammatory arthritis

A
  1. IMPA–erosive ( RA, PA of GH, feline chronic progressive PA)–nonerosive: IMPA (I-idiopathic, II-reactive, III-GI, IV-neoplastic), drug induced (sulfonamides/Dobies); SLE, Sharpeis/Akita breed related arthropathies2. infective arthropathy3. crystal induced (Ca, urate, hydroxyapatite)
36
Q

rheumatoid factor

A

IgM (and IgA) autoantibodies against Fc portion of IgGserology for presence of these Ab aids in dx but may also be raised with other chronic inflammatory diseases

37
Q

MOA of bacterial infective arthropathy

A
  1. hematogenous spread (second most common)2. direct penetration/trauma3. local spread from tissues (most common)dog most common: Staph intermedius, Staph aureus, beta hemolytic Strepcat: pastuerella, bacteroides
38
Q

most frequent cause of infxn (infective arthropathy) in dogs/cats

A

post op infection following articular surgerytarsus, stifleex. 6.1% after TPLO surgery within 6 months; decr risk with using suture over staples and post op Ab administration but wound infections leading to osteomyelitis or septic arthritis are uncommon

39
Q

T/FNerve endings are present on articular cartilage

A

FALSE free nerve endings are present in all structures of the joint EXCEPT articular cartilage

40
Q

radiographic features of OA

A

SSS EE I Osoft tissue swellingsubchondral sclerosis *subchondral cystEffusionenthesiophytosisintra articular mineralizationosteophytosis * (usually at bone/cartilage junction)

41
Q

MOA of bone scintigraphy

A

technetium is linked to diphosphonate carrierthe diphosphonate binds hydroxyapatite crystals and recently formed bone has large crystals for the carrier to bind”hot spot”

42
Q

codeine

A

mu agonist5-10% convert to morphinealone schedule IIwith APAP schedule III

43
Q

MOA of essential poly unsaturated fatty acids

A

PUFA (contain more than 1 carbon -carbon double bond): linoleic (6), linolenic (3)1. components in cell membranes2. involved in lipid transport3. serve as precursors to eicosanoid formation which regulates inflammatory process3-FA may decr mRNA for proteinases and MMPs and increase PVF days btwn days 0-90 on diet with hi omega 3 and owners subjectively thought they improved

44
Q

idiopathic or type I IMPA (nonerosive)

A

accounts for 50% of IMPA usually carpi/tarsi affectsystemically can have pyrexia, lymphadenopathymost dogs respond well to initial immunosuppresive therapy (prednisone, leflonomide, azathioprine) BUT 31% relapse

45
Q

diagnosis of SLE (non erosive inflammatory IMPA) with multi systemic dz

A

ANTINUCLEAR ANTIBODY TITERpyrexia with polyarthropathy+/- skin lesions (mucocutaneous junction)+/- meningitis+/- ophtho signs+/- hemolytic anemia +/- glomerular diseasetiters >160 somewhat guarded prognosis with immunosuppresive therapy

46
Q

how many joint fluid samples are recommended to aid in diagnosis of IMPA

A

3 fluid samples from different joints

47
Q

which drug and dog breed has the most apparent association with IMPA

A

sulfonamidesDoberman Pinschers

48
Q

joints most commonly affected with IMPA vs septic arthritis

A

IMPA —carpi, tarsiseptic –elbows, stifles, carpus

49
Q

treatment options for septic/infective arthritis

A
  1. joint aspiration2. joint irrigation3. arthrotomy, lavage4. arthroscopy, lavage5. synovectomy6. systemic Ab7. local Ab 28 d then recheck cytology8. Combo
50
Q

According to Vanderweek JVIM 2012, the efficacy of nutraceuticals in dogs is poor with the exception of what

A

diets supplemented with omega 3 FA

51
Q

two breed related IMPA (non erosive)

A

Akitas Sharpei

52
Q

rheumatoid arthritis pannus

A

destruction of the articular cartilage and subchondral bone associate with an invasive tissue in jointsstifle>carpus>hip>elbow>tarsus

53
Q

three types of erosive IMPA

A
  1. RA2. PA of GH3. Feline chronic progressive PA
54
Q

criteria for diagnosing bacterial infective/septic arthritis

A
  1. typical hx and clinical signs2. synovial fluid cytology >40% PMN and high TNCC3. + culture (use blood cultures, sample >1) can get FN

TnJ (128 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions